pharmaceutical jobs, careers, and e-learning/training Employers, Biotechnology And Pharmaceutical Firms: Subscribe Now, Post Your Job Openings, Search Resumes, Find Candidates Pharmaceutical Job Search Post Your Pharm/biotech Resume               
  Pharmaceutical Jobs, Learning Resources, Career Tools

2010: A Year of Big Layoffs for Big Pharma

Thursday, October 21, 2010 at 12:00:00 AM


According to the newly released Job-Cut Announcement Report from outplacement consultancy firm Challenger, Gray & Christmas, pharma has cut more than 6,000 jobs in September alone, and more than 43,000 so far this year.

Which companies have contributed to this staggering number, and what are the underlying causes of job losses in the industry?

Most recently, Sanofi-Aventis announced its plans to eliminate 1,700 jobs in its US pharma business—about 25 percent of the company’s US pharma workers. The majority of jobs lost will be sales positions, and a small number of administrative jobs will disappear as well.

Before that, in September, Roche announced its “Operational Excellence Initiative,” which—while partly intended to analyze and restructure different segments of the company to maximize productivity and ROI—ultimately amounted to job cuts in an effort to “set the right priorities to ensure a successful future,” according to a statement released by Roche.

In May, Pfizer announced 6,000 layoffs that it said was part of “manufacturing reorganization” following its 2009 Wyeth acquisition. Possibly part of its plan to remain on track for its targeted cost reduction of $4 to $5 billion by the end of 2012, Pfizer has gone from nearly 114,000 employees internationally in Q 1 2010 to around 33,000 as of May of this year, according to a story on DailyFinance.com.

Following its 2009 acquisition of Schering-Plough, Merck began making cuts in February. The post-merger cuts would be a way to “eliminate some of the duplication,” according to a statement made in January by Merck CEO Dick Clark. “We have taken the best from both companies, from a process standpoint and a people standpo...

NOTE: Article text has been summarized. Click here for the entire post.

Pharma Companies Bring in Big Investments

  Research companies are getting large investments, but are they hiring?

Thursday, August 19, 2010 at 12:00:00 AM


It appears pharma companies in Philadelphia are bringing in big investments...

Last week, TetraLogic Pharmaceuticals Corp., of Malvern, said it raised $32 million in its latest financing, which was led by Clarus Ventures L.L.C., of Cambridge, Mass.

Other investors included Amgen Ventures , of 
San Diego; Hatteras Venture Partners, of Durham, N.C.; HealthCare Ventures L.L.C., of Princeton; Posted By Rich Kneece.
Other posts in the Job and Hiring Trends category.

Tags: Hiring  Investment  Jobs  Pharmaceutical  Research  Trends  

House strikes gift ban in effort to boost business

Thursday, July 08, 2010 at 12:00:00 AM


Reversing course on a new law aimed at diminishing the influence on doctors of pharmaceutical and medical device companies, the House on Wednesday voted to strike the so-called gift ban law, which critics say has hurt commerce in the medical and restaurant industries.

An amendment to preserve the ban attracted 40 votes, with 108 against. The elimination of the gift ban was included in economic development legislation that cleared the House 145-4 and now needs to be reconciled with a Senate bill in a conference committee.

Critics of the ban said it was discouraging out-of-state interests from doing business in Massachusetts and said the ban had not led to demonstrable reductions in health-care costs. Supporters of the ban said the state had already heavily invested itself in implementing it and needed to give the law more time to work itself out. Ban supporters also said other states were pursuing similar bans and predicted the law could help reduce health-care costs and ensure that the interests of patients, not drug and device makers, are the top priority for physicians.

Speaking against the ban were Reps. Garrett Bradley, Brian Dempsey and Barry Finegold. Pushing to preserve the ban were Reps. Alice Wolf, Ruth Provost, Jason Lewis and Elizabeth Malia.

See the entire article at Mass High Tech....

NOTE: Article text has been summarized. Click here for the entire post.

Have Sunshine Laws Left Companies in the Dark?

  Sunshine Laws Stump Compliance Departments

Thursday, April 29, 2010 at 10:57:00 AM


The federal Physician Payment Sunshine Act. State disclosure laws in Vermont and Massachusetts. More disclosure laws in possibly dozens of other states in the near future. It’s enough to make a compliance department throw up its hands and leave the hassle to a third party—which is exactly what many pharma companies are doing now or plan to do in the future, according to a new study conducted by Cegedim Dendrite.

The respondents—56 professionals working in the compliance departments at their respective pharma/biotech/medical device companies—expect that the farming out of this data collection will increase the cost of aggregate spend reporting and compliance over the next year. But most have little choice, as this wave of legislation seems to have caught them with their pants down.

See entire article at
PharmExec.

MTC has created several apps that allow pharmaceutical and device companies to manage, track, report on, and process payments to medical professionals. Contact us today to see how we can help you

...

NOTE: Article text has been summarized. Click here for the entire post.